On August 28, 2019, Jeff Conroy joined the Board of Odyssey Group International, Inc. as an independent director. Mr. Conroy is an operating and business development executive with over 30 years in the life science industry across therapeutics and medical devices. Mr. Conroy is the Chairman & CEO of Embody. Since 2012, he has served as the Head of Corporate Development for Especificos Stendhal S.A. de C.V. He is the Managing Director of Windward Investments - structuring licensing partnerships for life science companies. Mr. Conroy is an independent director of Cingulate Therapeutics, a CNS company developing ADHD therapeutics.